Conditions: Type2 Diabetes High Blood Sugar
Keywords: Phase3 Clinical trial Type 2 Diabetes Mellitus
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 728
Healthy volunteers: no

Brief summary:
This is a long term, single arm, open label study to evaluate the safety and efficacy of dapagliflozin as monotherapy or in combination therapy with other anti diabetic drug in Japanese subjects with type 2 diabetes mellitus who have inadequate blood sugar control on diet and exercise or on other anti-diabetic treatment will be included in this study.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Dapagliflozin
Intervention descriptions: intervention 1: Oral Dose 5 or 10 mg

Protocol document: